April 11, 2024
SAN RAMON, Calif. — In an effort to make the entry into myopia management easier for practitioners, CooperVision has released a new QuickStart training program. The company announced that it will also be expanding its myopia management team to provide ECPs additional support through their myopia management journeys.
The MiSight 1 day QuickStart program, accessible via CooperVision’s Online Success Center, caters to ECPs at various stages of their prescribing journey with MiSight 1 day, the first and only FDA-approved* soft contact lens proven to slow the progression of myopia in children, aged 8-12 at the initiation of treatment.†1
The tools include written guides, a series of short videos, and amplified support from CooperVision’s Myopia Management Specialist team members, allowing ECPs to tailor their learning experiences. The topics span from essential clinical information required for initiating treatment to effective communication strategies with parents, ensuring their entire practice is engaged in supporting patients.
“CooperVision strives to make prescribing as easy as possible for ECPs, especially with a growing number who want to take an active role in combatting the growing prevalence of myopia” said Justin Kwan, OD, FAAO, who has been promoted to Head, Myopia Management. “Our MiSight1 day QuickStart program accelerates this pathway. It facilitates myopia treatment for children, which has the potential to positively impact their lives and improve the trajectory of their vision health.”‡2,3
CooperVision is also expanding its U.S. professional myopia team to ensure that every practicing ECP has access to specialized expertise. Priscilla Chang, OD, FAAO, IACMM, has joined CooperVision as Senior Manager, Myopia Management. Dr. Chang previously served as a Clinical Sales Consultant for Johnson & Johnson Vision. She joins Leah Johnson, OD, FAAO, FSLS, FBCLA, and Felicia Timmermann, OD, MS, FAAO, Senior Managers, Myopia Management. These experienced professionals bring deep knowledge in myopia control to their support of doctors and staff, under Dr. Kwan’s leadership.
“CooperVision’s commitment to providing the eye care community with the highest quality tools, products, and services starts first by investing in our people,” said Dr. Kwan. “Through this team of Drs. Chang, Johnson, and Timmermann, we’re elevating peer-to-peer interaction, practice support, and education across the country, while helping the profession establish myopia management as the standard of care.”4
References
*Indications for use: MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
† Compared to a single vision 1 day lens over a three year period.
‡ 77% strongly agree, 20% somewhat agree.
- Chamberlain P, et al. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567.
- Rah MJ, et al. Vision specific quality of life of pediatric contact lens wearers. Optom Vis Sci. 2010;87(8):560-6.
- CVI data on file 2022. U.S. CooperVision online survey: ECP MiSight 1 day Perspectives; n=101 ECPs that prescribe MiSight 1 day
- Resolution: The standard of care for Myopia Management by Optometrists. World Council of Optometry. (2021, May 17). https://
worldcouncilofoptometry.info/ resolution-the-standard-of- care-for-myopia-management-by- optometrists.
